Protalix BioTherapeutics, Inc. (PLX) ownership: Top institutional holder: BlackRock, Inc. ($7.85M). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| BlackRock, Inc. | 3616962.00 | $7.85M | 2026-03-31 |
| MAK CAPITAL ONE LLC | 3544139.00 | $7.69M | 2026-03-31 |
| RENAISSANCE TECHNOLOGIES LLC | 1224800.00 | $2.66M | 2026-03-31 |
| STATE STREET CORP | 972815.00 | $2.11M | 2026-03-31 |
| NORTHERN TRUST CORP | 885448.00 | $1.92M | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 865298.00 | $1.88M | 2026-03-31 |
| Stratos Wealth Partners, LTD. | 500000.00 | $1.08M | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 432485.00 | $938492.00 | 2026-03-31 |
Back to PLX overview · PLX earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.